44 results
8-K
EX-1.2
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
believes to be (i) a QIB or (ii) an institutional “accredited investor”.
Section 2. Engagement of Placement Agents; Fees; Expenses.
(a) Engagement … to place the Shares and the PFWs as contemplated by this Agreement. The Company acknowledges that the Placement Agents’ engagement hereunder does
8-K
EX-99.1
19x1g8n0dib6goxgenl
10 Jul 23
Regulation FD Disclosure
4:06pm
424B5
bo5uyyn8pw bkn
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
xzgdd xuvh
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-10.1
2761p690w90fk
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
424B5
mxoxx943g1c1u6
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
3ndn8
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
wohprn76dv ns
15 Nov 19
Departure of Directors or Certain Officers
4:37pm
8-K
EX-10.1
rnqcmwiqtc5 ivd
15 Nov 19
Departure of Directors or Certain Officers
4:37pm